Table 2.
- Distribution and risk of the ABO blood group in 2617 patients with COVID-19 (N=2617).
| Rh positive (2171) | Rh negative (446) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| A 724 (27.7) |
B 624 (23.8) |
AB 379 (14.5) |
†non-O 1727 (66.0) |
O 890 (34.0) |
||||||
| A+ | A- | B+ | B- | AB+ | AB- | + | - | O+ | O- | |
| *Reference population (Makkah area) | ||||||||||
| 5000 | 1314 (26.3) | 101 (2.0) | 883 (17.66) | 81(1.6) | 216(4.3) | 8(0.2) | 2413 (48.3) | 190 (3.8) | 2190 (43.8) | 207 (4.1) |
| Patients | ||||||||||
| 2617 | 620 | 104 | 474 | 150 | 297 | 82 | 1391 | 336 | 780 | 110 |
| RR | 0.977 | 1.24 | 3.23 | 1.16 | 0.783 | |||||
| 95% CI | 0.883-1.082 | 1.124-1.382 | 2.702–3.821 | 1.107–1.218 | 0.733–0.836 | |||||
| P-value | 0.6 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | |||||
| Died | Rh positive (58) | Rh negative (19) | ||||||||
| 77 | 16 | 5 | 10 | 8 | 11 | 2 | --- | --- | 21 | 4 |
| RR | 0.988 | 0.984 | 1.14 | 0.965 | ||||||
| 95% CI | 0.673-1.452 | 0.645-1.501 | 0.684-1.904 | 0.683 - 1.304 | ||||||
| P-value | 0.9 | 0.9 | 0.6 | 0.8 | ||||||
†
blood group non-O (A,B and AB), *Reference population, 18 RR: relative risk, CI: confidence interval